Key Takeaways
An Aqualyx consent form is a medical document that confirms a patient understands the fat-dissolving injection procedure, its risks, contraindications, and post-treatment care before treatment begins.
Consent forms must cover the treatment mechanism (deoxycholic acid injection), expected outcomes, common side effects (swelling, bruising, nodules), contraindications (pregnancy, liver disease, active infection), and a patient declaration of informed understanding.
Aqualyx is not FDA-approved. The only FDA-approved injectable deoxycholic acid is Kybella, cleared to reduce fat under the chin. A practice that offers Aqualyx should disclose this clearly in the consent form and document the patient’s understanding.
Pabau’s digital forms feature lets your practice collect, store, and manage Aqualyx consent documents electronically, reducing paper workflows and keeping records audit-ready and HIPAA-compliant.
Download Your Free Aqualyx Consent Form Template
A ready-to-use consent form covering patient details, medical history, Aqualyx treatment information, contraindications screening, risk and side-effect disclosure, marketing-communication consent, photography consent, practitioner declaration, and signature blocks. Editable and HIPAA-aligned.
An Aqualyx consent form is a legal document that records a patient’s informed consent before fat-dissolving injection treatment. This template provides medical forms that support clinical workflows while giving every patient clear written information about the Aqualyx procedure, its potential risks, and their rights.
What is an Aqualyx consent form?
An Aqualyx consent form documents that a patient fully understands the fat-dissolving injection procedure before treatment. Aqualyx, developed by Prof. Pasquale Motolese and presented in 2004, uses deoxycholic acid – a secondary bile acid formed when gut bacteria metabolize the body’s bile acids – to dissolve localized pockets of fat beneath the skin.
The form serves two purposes: it confirms informed consent, and it creates a documented record for your practice. A properly completed consultation and consent template shows that you explained the procedure, risks, alternatives, and post-treatment expectations before any treatment began.
In the US, informed consent for elective cosmetic procedures is governed by state law, state medical board requirements, and common-law consent doctrine. The AMA’s informed consent guidance sets out the core duty to give patients the information they need to make a decision. A missing or incomplete consent form leaves your practice exposed if a complaint or malpractice claim arises.
How to use the template
This template follows a five-step workflow that aligns with US aesthetic practice standards:
- Patient information section: Capture the patient’s full name, date of birth, contact details, and a practice reference number. This ensures the form is correctly matched to the patient’s clinical record.
- Medical history questionnaire: Screen for absolute contraindications (pregnancy, active infection, liver disease, lipid disorders, anticoagulation therapy) and relative contraindications (recent immunizations, uncontrolled diabetes, keloid tendency). This section protects against treatment in unsuitable candidates.
- Treatment description and mechanism: Explain what Aqualyx is, how deoxycholic acid breaks down fat cells, the expected treatment course (typically 2–8 sessions), and realistic outcomes. Clarity here reduces unrealistic patient expectations.
- Risks and side effects disclosure: Document all known side effects including swelling (can last 5–7 days), bruising, nodule formation, skin necrosis (rare but serious), infection, and allergy. Name specific risks rather than describing them in general terms.
- Patient declaration and signature: The patient confirms reading and understanding all information, having had questions answered, and consenting to proceed. Include the date and practitioner signature to create an auditable record.
Additional sections should include digital consent forms for paperless capture, photography consent (ask separately whether images may be taken and used for before-and-after records), and a notice confirming the patient’s right to withdraw consent at any time before treatment.

Who needs this consent form?
Any US aesthetic practice or independent practitioner offering deoxycholic acid injections needs a robust consent form. This includes:
- Medical spas and aesthetic practices
- Dermatology practices offering nonsurgical fat reduction
- Aesthetic nurses and practitioners working under medical supervision
- Nurse practitioners and physician assistants with appropriate training
- Multi-location practice groups needing standardized consent documentation
Whether you are a solo practitioner or a large practice group, a professionally drafted consent form demonstrates clinical governance and reduces malpractice risk. Patients appreciate transparency, and medical spa management software can automate consent collection, making the process frictionless.
Benefits of using a consent template
- Legal compliance: A written consent form satisfies the requirement for informed consent before invasive treatment. It creates an auditable record that protects your practice if questions arise.
- Clinical safety: Screening for contraindications before treatment prevents complications in unsuitable patients. Documenting risks ensures patients make informed decisions.
- Operational efficiency: Using a standardized template ensures every patient receives the same information and every form contains all required sections, so contraindications are never missed.
- Regulatory readiness: If a complaint, malpractice claim, or state medical board inquiry arises, a complete, dated, signed form demonstrates that you met the standard of care. Data protection and compliance management tools help you manage these records securely.
- Patient trust: Clear, comprehensive consent shows professionalism and respect for patient autonomy. Patients who feel informed are more satisfied and less likely to pursue complaints.
Streamline consent capture with digital forms
Pabau’s digital forms feature lets your practice collect Aqualyx consent electronically, store signed documents securely, and generate audit-ready, HIPAA-compliant reports in minutes.

Data protection and HIPAA in your consent form
US practices must comply with HIPAA when collecting and storing patient information during consent. Your Aqualyx consent form should include:
- A section explaining how protected health information (PHI) will be used and disclosed for treatment, payment, and operations
- Separate opt-ins for email and text-message marketing (kept separate from clinical consent, and compliant with the TCPA and CAN-SPAM Act)
- A Notice of Privacy Practices explaining data retention, storage security, and patient rights to access and amend their records
- Clear language confirming the patient understands their information is stored in the practice system and used for their care
The U.S. Department of Health and Human Services publishes HIPAA guidance for healthcare providers. Practices should ensure HIPAA compliance management tools are in place to track consent, manage records requests, and prepare for an audit. Bundling marketing consent with clinical consent – or texting patients without prior express consent – is a common compliance failure.

Key sections your consent form should include
A comprehensive consent template covers six core areas:
- Patient demographics and contact: Name, DOB, address, emergency contact, practice reference number
- Aqualyx treatment information: What the product is (fat-dissolving injectable), how it works (deoxycholic acid mechanism), number of expected sessions, timeline to results
- Medical history and contraindications checklist: Absolute contraindications (pregnancy, liver disease, active infection, anticoagulant use) and relative contraindications (keloid tendency, diabetes, immunosuppression)
- Realistic outcomes and limitations: Results vary; multiple treatments are needed; not suitable for all body areas; note that Aqualyx is not FDA-approved
- Risks and side effects: Short-term (swelling, bruising, tenderness, numbness), medium-term (nodule formation), rare (skin necrosis, nerve damage, infection)
- Practitioner information and signature: Practitioner name, credentials, state license, malpractice insurance details, planned treatment date
A modern consent form should also support paperless consent capture workflows that let patients review and sign electronically, creating tamper-evident digital records.
Photography and before-and-after consent
Request explicit, separate consent for clinical photography. Patients should be asked whether before-and-after images may be taken, stored in their clinical record, and (separately) used for marketing or educational purposes. Never bundle photography consent with medical consent – these are distinct permissions.
Right to withdraw consent
A patient may withdraw consent at any time before treatment. Elective cosmetic procedures performed in your office are not covered by a federal cooling-off rule, but it is good practice to confirm in writing that the patient understands they can withdraw consent before treatment begins, and to set out your practice’s cancellation and refund policy.
FDA status and regulatory requirements for Aqualyx in the US
Aqualyx is not FDA-approved. The FDA has warned that fat-dissolving injections sold under brand names such as Aqualyx have not been evaluated for safety or effectiveness, and that the only FDA-approved injectable deoxycholic acid is Kybella, cleared to reduce submental (under-chin) fat in adults.
Because Aqualyx is unapproved in the US, a practice that chooses to offer it should disclose this clearly in the consent form and document the patient’s understanding. State medical boards and informed-consent law govern how these procedures may be offered and by whom.
Practitioners should hold the appropriate state license and credentials, work within their scope of practice (or under proper physician delegation and supervision), and carry malpractice insurance for the procedure. Your consent form should reference the treating practitioner’s credentials and confirm coverage.
Common mistakes to avoid
Generic language: A form copied from another procedure or practice may miss Aqualyx-specific risks (nodule formation, delayed swelling) or contraindications (liver disease). Customize your form to the product and your practice.
Incomplete contraindications screening: Missing questions about pregnancy, anticoagulant therapy, or active infection allows unsuitable candidates to proceed, creating patient harm and liability exposure.
Vague risk disclosure: “There may be side effects” is not enough. Name the specific risks (swelling, bruising, nodules, infection) and quantify where data exists. Vague language suggests you did not properly inform the patient.
Missing practitioner details: A consent form that does not name the practitioner, their credentials, or the practice is harder to defend if complications arise. Always include practitioner signature, date, and license details.
Not disclosing FDA status: Because Aqualyx is not FDA-approved, failing to tell patients this – and document that they understood it – is a serious informed-consent failure.
Conclusion
An Aqualyx consent form is the foundation of clinical governance and patient protection. This free template covers all required elements: patient information, medical history screening, treatment details, honest risk disclosure including FDA status, and legally compliant signature sections. Download the template today, customize it to your practice’s specific protocols and practitioner details, and ensure every Aqualyx patient signs before treatment begins. For seamless digital consent capture that integrates with your practice management system, book a demo with Pabau to see how automated workflows reduce paperwork while keeping you audit-ready.
Frequently asked questions
A comprehensive consent form covers patient demographics, medical history screening (contraindications), Aqualyx treatment information, realistic outcomes, specific risks and side effects, photography consent, the right to withdraw consent, and practitioner signature with date and credentials.
No. Aqualyx is not FDA-approved in the US. The only FDA-approved injectable deoxycholic acid is Kybella, cleared to reduce fat under the chin. The FDA has warned against using unapproved fat-dissolving injections.
Absolute contraindications include pregnancy, active infection, liver disease, lipid disorders, and anticoagulant therapy. Relative contraindications include diabetes, keloid tendency, immunosuppression, and recent immunizations. Always screen patients thoroughly before treatment.
Common side effects are swelling and bruising (typically resolve within 5–7 days), tenderness, and temporary numbness. Rare but serious risks include nodule formation, skin necrosis, nerve damage, and infection. Honest risk disclosure in your consent form is essential.
Yes. A medical history questionnaire screening for contraindications (pregnancy, liver disease, infection, anticoagulation) is mandatory before Aqualyx treatment to identify unsuitable candidates and prevent complications.